Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing, and pathological evaluation. The platform can assist in linking teams of authoritative experts at home and abroad to provide accurate diagnoses and treatment programs. Treatment and management of the S-deficiency treatment program require multi-dimensional development, typically including drug therapy, rehabilitation interventions, and regular follow-up.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat blood tumor diseases have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner depending on changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of protein S deficiency.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.